Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 235,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
성장 중
회사는 성장 단계에 있으며, 최신 연간 수익은 미화 31.99M에 달합니다.
이익 전환
회사의 실적이 흑자로 전환되어, 최근 연간 순이익은 미화 402.10K달러에 달합니다.%!(EXTRA int=2)
과소 평가된
회사의 최신 PE은 -250.26로, 최근 3년 기준 낮은 백분위 범위에 속합니다.
기관 매도
최신 기관 보유 주식 수는 4.28M주이며, 전 분기 대비 0.16% 감소했습니다.